KT185 is primarily utilized in research and development within the field of biochemistry and pharmacology. It serves as a selective inhibitor of the protein kinase SGK3 (serum and glucocorticoid-regulated kinase 3), making it a valuable tool for studying cellular signaling pathways. Researchers use KT185 to investigate the role of SGK3 in various biological processes, including cell survival, proliferation, and differentiation. Its application is particularly significant in cancer research, where SGK3 is implicated in tumor growth and resistance to therapy. By inhibiting SGK3, KT185 helps scientists understand its function and explore potential therapeutic strategies for cancer and other diseases linked to kinase activity. Additionally, KT185 is employed in preclinical studies to assess its efficacy and safety as a potential drug candidate.